Wealthspire Advisors (Maryland)’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Wealthspire Advisors (Maryland)'s BMY Position: Q3 2020 in Review
Wealthspire Advisors (Maryland) increased its Bristol-Myers Squibb (BMY) stake by 20% in Q3 2020, buying an estimated $276K and bringing the position to 27,934 shares worth $1.68M. The position accounts for 0.06% of the portfolio, ranked #144.
Wealthspire Advisors (Maryland) first reported a position in BMY in Q4 2015 and has held it in 20 quarters since. The position peaked at $1.9M in Q4 2019. 2,214 funds tracked by Wall St. Rank hold BMY as of Q3 2020.
- Wealthspire Advisors (Maryland) held 27,934 shares of Bristol-Myers Squibb worth $1.68M as of Q3 2020.
- Wealthspire Advisors (Maryland) bought 4,587 Bristol-Myers Squibb shares in Q3 2020, an estimated $276K.
- Bristol-Myers Squibb made up 0.06% of Wealthspire Advisors (Maryland)'s portfolio in Q3 2020, its #144 holding.
- Wealthspire Advisors (Maryland) first reported a position in Bristol-Myers Squibb in Q4 2015 and has held it in 20 quarters since.
- Wealthspire Advisors (Maryland)'s Bristol-Myers Squibb position peaked at $1.9M in Q4 2019.
- 2,214 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2020.
Based on Wealthspire Advisors (Maryland)'s 13F filing for Q3 2020, filed 13 Nov 2020.